Related Experiment Videos
[Invasive aspergillosis on a surgical intensive care unit]
1Klinik für Chirurgie, Universitätsklinikum Lübeck, Germany.
Mycoses
|April 9, 2001
Summary
Invasive aspergillosis is a rare but serious fungal infection in surgical intensive care units. Early diagnosis and treatment are crucial for patient outcomes, despite high mortality rates.
Area of Science:
- Medical Mycology
- Infectious Diseases
- Critical Care Medicine
Background:
- Invasive aspergillosis is a severe opportunistic infection.
- Surgical intensive care units (SICU) present unique challenges for managing invasive fungal infections.
Observation:
- A retrospective study identified 12 cases of invasive aspergillosis among 4777 patients in a SICU between 1995 and 2000.
- Patients presented with diverse manifestations, including mediastinitis, aspergilloma, and bronchoalveolar aspergillosis.
- The study population exhibited a high burden of risk factors for systemic mycoses and significant underlying comorbidities.
Findings:
- The primary treatment involved amphotericin B, often combined with flucytosine or itraconazole.
- Amphotericin B aerosol inhalation was used in some cases, and voriconazole was administered for therapeutic failures.
- A high mortality rate of 83% (10 out of 12 patients) was observed, with 7 deaths attributed to underlying conditions.
Implications:
- This study highlights the critical nature of invasive aspergillosis in SICU patients.
- Aggressive antifungal therapy is essential, but outcomes remain poor due to patient comorbidities.
- Further research into risk stratification and novel therapeutic strategies for invasive aspergillosis in critically ill patients is warranted.